0 items USD 0.00Search
Your search for "delveinsight chemotherapy induced neutropenia pipeline insights 2015" gave back 38305 results.
The “Chemotherapy-Induced Neutropenia Treatment Industry Forecast” looks at past sales and reviews total world Chemotherapy-Induced Neutropenia...
Catalog:
LPI
March 2023
Price: USD 3,660.00
The “Chemotherapy-Induced Nausea and Vomiting Drugs Industry Forecast” looks at past sales and reviews total world Chemotherapy-Induced Nausea and...
Catalog:
LPI
February 2023
Price: USD 3,660.00
Summary Chemotherapy Induced Nausea and Vomiting (CINV) Drugs market research report provides the newest industry data and industry future trends,...
Catalog:
ICRW
September 2020
Price: USD 2,960.00
Chemotherapy-Induced Nausea and Vomiting (CINV) is one of the devastating side effects for patients undergoing cancer treatment. It is caused when...
Catalog:
LPI
March 2023
Price: USD 3,660.00
Granulocyte-colony stimulating factor (G-CSF or GCSF), also known as colony-stimulating factor 3 (CSF 3), is a glycoprotein that stimulates the bone...
Catalog:
LPI
February 2023
Price: USD 3,660.00
Chemotherapy-Induced Nausea and Vomiting (CINV) is one of the devastating side effects for patients undergoing cancer treatment. It is caused when...
Catalog:
MRRPB5
June 2023
Price: USD 4,900.00
Chemotherapy-Induced Nausea and Vomiting (CINV) is one of the devastating side effects for patients undergoing cancer treatment. It is caused when...
Catalog:
MRRPB5
February 2024
Price: USD 2,900.00
The cancer supportive care product market consists of drugs intended to prevent or treat the symptoms of cancer, and reduce the side effects of...
Catalog:
LPI
February 2023
Price: USD 3,660.00
Chemotherapy-Induced Nausea and Vomiting (CINV) is one of the devastating side effects for patients undergoing cancer treatment. It is caused when...
Catalog:
MRRPB5
April 2023
Price: USD 2,900.00
The cancer supportive care product market consists of drugs intended to prevent or treat the symptoms of cancer, and reduce the side effects of...
Catalog:
GIR
January 2023
Price: USD 3,480.00
Pegfilgrastim is developed by PEGylating the recombinant human granulocyte colony-stimulating factor (G-CSF) analogue, filgrastim. Pegfilgrastim was...
Catalog:
LPI
February 2023
Price: USD 3,660.00
The cancer supportive care product market consists of drugs intended to prevent or treat the symptoms of cancer, and reduce the side effects of...
Catalog:
LPI
March 2023
Price: USD 3,660.00
The global Cancer Supportive Care market size was valued at US$ 21650 million in 2023. With growing demand in downstream market, the Cancer...
Catalog:
LPI
February 2024
Price: USD 3,660.00
Febrile neutropenia, one of the most severe complications during cancer chemotherapy, is the development of fever with infection signals. The “...
Catalog:
LPI
February 2023
Price: USD 3,660.00
Neutropenia is a clinical condition characterized by a decrease in neutrophil count in the blood, resulting in a higher risk of developing serious...
Catalog:
LPI
February 2023
Price: USD 3,660.00
